Sorafenib alone vs. sorafenib plus GEMOX as 1st-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial
暂无分享,去创建一个
M. Ychou | E. Assenat | Y. Bécouarn | V. Boige | O. Bouché | M. Ramdani | J. Blanc | J. Seitz | J. Péron | P. Merle | G. Pageaux | S. Thézénas | S. Poujol | H. De forges